NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding NexImmune, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 12 | 13 | +1 |
| Shares | 153.0K | 148.1K | −4.84K (−3.2%) |
| Value | $858.3K | $408.6K | −$449.7K (−52.4%) |
New holders (2)
Institutions that held NexImmune, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 4,000 | $11.1K | 0.00% |
| Bank of America Corp | 7 | $19 | 0.00% |
Sold out (1)
Institutions that held NexImmune, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Wells Fargo & Company | 7 | $39 |